UFF
VIVO

USA Financial Formulas’s Meridian Bioscience Inc VIVO Stock Holding History

USA Financial Formulas’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,784
Closed -$47K – 431
2020
Q3 		$47K Buy
+2,784
New +$54.1K 0.04% 118

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

USA Financial Formulas's VIVO Position: Q4 2020 in Review

USA Financial Formulas sold out of Meridian Bioscience Inc (VIVO) in Q4 2020, closing a stake of 2,784 shares — an estimated $47K sold.

USA Financial Formulas first reported a position in VIVO in Q3 2020 and held it in 1 quarter. The position peaked at $47K in Q3 2020. 192 funds tracked by Wall St. Rank hold VIVO as of Q4 2020.

  • USA Financial Formulas reported no remaining Meridian Bioscience Inc position as of Q4 2020 after selling out during the quarter.
  • USA Financial Formulas sold 2,784 Meridian Bioscience Inc shares in Q4 2020, an estimated $47K.
  • USA Financial Formulas first reported a position in Meridian Bioscience Inc in Q3 2020 and held it in 1 quarter.
  • USA Financial Formulas's Meridian Bioscience Inc position peaked at $47K in Q3 2020.
  • 192 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2020.

Based on USA Financial Formulas's 13F filing for Q4 2020, filed 29 Jan 2021.